Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
Condition: Irritable Bowel Syndrome of Diarrhea Type (IBS-D) Interventions: Drug: OPS-2071; Drug: placebo Sponsor: Otsuka Beijing Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials